- $13.85bn
- $20.87bn
- $1.74bn
- 61
- 55
- 70
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,233 | 1,209 | 1,332 | 1,479 | 1,741 |
Cost of Revenue | |||||
Gross Profit | 1,076 | 1,089 | 1,207 | 1,325 | 1,519 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 754 | 692 | 727 | 867 | 1,015 |
Operating Profit | 478 | 518 | 605 | 612 | 726 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 333 | 445 | 439 | 626 | 752 |
Provision for Income Taxes | |||||
Net Income After Taxes | 307 | 461 | 410 | 598 | 708 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 305 | 455 | 410 | 599 | 708 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 305 | 455 | 410 | 599 | 708 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.98 | 2.48 | 2.13 | 3.2 | 2.29 |
Dividends per Share |